CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis Nitrosative stress drives heart failure with preserved ejection fraction From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) The year in cardiovascular medicine 2020: heart failure and cardiomyopathies Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction Heart Failure Outcomes With Volume-Guided Management The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure

Clinical Trial2018 Apr 12;378(15):1386-1395.

JOURNAL:N Engl J Med. Article Link

Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure

Mehra MR, Goldstein DJ, MOMENTUM 3 Investigators. Keywords: Magnetically Levitated Left Ventricular Assist Device; heart failure; pump thrombosis;

FULL TEXT PDF